Trillion Dollar Shot, Episode 4: The Disruptors
The Journal.
Transforming Obesity Treatments
This chapter examines the evolution of a pharmaceutical company as it addresses obesity, drawing comparisons to past advancements such as Prozac. It highlights ongoing innovations, including the experimental drug retitrutide, and the competitive landscape of GLP-1 medications aimed at weight loss. The discussion emphasizes the importance of continued research and the potential benefits these new treatments can have on patients' health.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
